Identification of Conserved Amino Acid Residues in Rat Liver Carnitine Palmitoyltransferase I Critical for Malonyl-CoA Inhibition

Carnitine palmitoyltransferase (CPT) I, which catalyzes the conversion of palmitoyl-CoA to palmitoylcarnitine facilitating its transport through the mitochondrial membranes, is inhibited by malonyl-CoA. By using the SequenceSpace algorithm program to identify amino acids that participate in malonyl-CoA inhibition in all carnitine acyltransferases, we found 5 conserved amino acids (Thr314, Asn464, Ala478, Met593, and Cys608, rat liver CPT I coordinates) common to inhibitable malonyl-CoA acyltransferases (carnitine octanoyltransferase and CPT I), and absent in noninhibitable malonyl-CoA acyltransferases (CPT II, carnitine acetyltransferase (CAT) and choline acetyltransferase (ChAT)). To determine the role of these amino acid residues in malonyl-CoA inhibition, we prepared the quintuple mutant CPT I T314S/N464D/A478G/M593S/C608A as well as five single mutants CPT I T314S, N464D, A478G, M593S, and C608A. In each case the CPT I amino acid selected was mutated to that present in the same homologous position in CPT II, CAT, and ChAT. Because mutant M593S nearly abolished the sensitivity to malonyl-CoA, two other Met593mutants were prepared: M593A and M593E. The catalytic efficiency (V max/K m ) of CPT I in mutants A478G and C608A and all Met593 mutants toward carnitine as substrate was clearly increased. In those CPT I proteins in which Met593 had been mutated, the malonyl-CoA sensitivity was nearly abolished. Mutations in Ala478, Cys608, and Thr314 to their homologous amino acid residues in CPT II, CAT, and ChAT caused various decreases in malonyl-CoA sensitivity. Ala478 is located in the structural model of CPT I near the catalytic site and participates in the binding of malonyl-CoA in the low affinity site (Morillas, M., Gómez-Puertas, P., Rubı́, B., Clotet, J., Ariño, J., Valencia, A., Hegardt, F. G., Serra, D., and Asins, G. (2002) J. Biol. Chem. 277, 11473–11480). Met593 may participate in the interaction of malonyl-CoA in the second affinity site, whose location has not been reported.

[1]  G. Ronnett,et al.  The connections between C75 and obesity drug-target pathways. , 2005, Trends in pharmacological sciences.

[2]  L. Tong,et al.  Crystal Structure of Mouse Carnitine Octanoyltransferase and Molecular Determinants of Substrate Selectivity*[boxs] , 2005, Journal of Biological Chemistry.

[3]  T. Seng,et al.  C75 [4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic Acid] Activates Carnitine Palmitoyltransferase-1 in Isolated Mitochondria and Intact Cells without Displacement of Bound Malonyl CoA , 2005, Journal of Pharmacology and Experimental Therapeutics.

[4]  D. Haro,et al.  Pig muscle carnitine palmitoyltransferase I (CPTI beta), with low Km for carnitine and low sensitivity to malonyl-CoA inhibition, has kinetic characteristics similar to those of the rat liver (CPTI alpha) enzyme. , 2004, Biochemistry.

[5]  R. Ramsay,et al.  Carnitine acyltransferases and their influence on CoA pools in health and disease. , 2004, Molecular aspects of medicine.

[6]  M. Golovko,et al.  An improved method for tissue long-chain acyl-CoA extraction and analysis Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.D400004-JLR200 , 2004, Journal of Lipid Research.

[7]  Antonio G. Cordente,et al.  Redesign of Carnitine Acetyltransferase Specificity by Protein Engineering* , 2004, Journal of Biological Chemistry.

[8]  G. Ronnett,et al.  Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. , 2004, American journal of physiology. Endocrinology and metabolism.

[9]  B. Corkey,et al.  Increased β-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation* , 2004, Journal of Biological Chemistry.

[10]  Alfonso Valencia,et al.  Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal. , 2004, The Biochemical journal.

[11]  E. Park,et al.  Peroxisomal proliferator activated receptor gamma coactivator (PGC-1alpha) stimulates carnitine palmitoyltransferase I (CPT-Ialpha) through the first intron. , 2004, Biochimica et biophysica acta.

[12]  M. Lane,et al.  Hypothalamic malonyl-CoA as a mediator of feeding behavior , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[14]  Roberto Conti,et al.  Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.

[15]  D. Arvidson,et al.  Substitution of glutamate-3, valine-19, leucine-23, and serine-24 with alanine in the N-terminal region of human heart muscle carnitine palmitoyltransferase I abolishes malonyl CoA inhibition and binding. , 2003, Archives of biochemistry and biophysics.

[16]  R. McKenna,et al.  Structure of Human Carnitine Acetyltransferase , 2003, The Journal of Biological Chemistry.

[17]  J. Dai,et al.  Identification by Mutagenesis of Conserved Arginine and Glutamate Residues in the C-terminal Domain of Rat Liver Carnitine Palmitoyltransferase I That Are Important for Catalytic Activity and Malonyl-CoA Sensitivity* , 2003, The Journal of Biological Chemistry.

[18]  Alfonso Valencia,et al.  Identification of Conserved Amino Acid Residues in Rat Liver Carnitine Palmitoyltransferase I Critical for Malonyl-CoA Inhibition , 2003, The Journal of Biological Chemistry.

[19]  L. Tong,et al.  Crystal Structure of Carnitine Acetyltransferase and Implications for the Catalytic Mechanism and Fatty Acid Transport , 2003, Cell.

[20]  R. Seeley,et al.  Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. , 2002, Diabetes.

[21]  Nigel Price,et al.  A novel brain-expressed protein related to carnitine palmitoyltransferase I. , 2002, Genomics.

[22]  P. Terpstra,et al.  Structural and Functional Genomics of the CPT1B Gene for Muscle-type Carnitine Palmitoyltransferase I in Mammals* , 2002, The Journal of Biological Chemistry.

[23]  G. Ronnett,et al.  C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Alfonso Valencia,et al.  Structural Model of a Malonyl-CoA-binding Site of Carnitine Octanoyltransferase and Carnitine Palmitoyltransferase I , 2002, The Journal of Biological Chemistry.

[25]  Monica V. Kumar,et al.  Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Schaffer Fatty acid transport: the roads taken. , 2002, American journal of physiology. Endocrinology and metabolism.

[27]  Monica V. Kumar,et al.  Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Montserrat Morillas,et al.  Structural Model of the Catalytic Core of Carnitine Palmitoyltransferase I and Carnitine Octanoyltransferase (COT) , 2001, The Journal of Biological Chemistry.

[29]  W. Winder Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. , 2001, Journal of applied physiology.

[30]  F. Kuhajda,et al.  Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. , 2001, Biochemical and biophysical research communications.

[31]  I. S. Pretorius,et al.  Carnitine‐dependent metabolic activities in Saccharomyces cerevisiae: three carnitine acetyltransferases are essential in a carnitine‐dependent strain , 2001, Yeast.

[32]  J. Girard,et al.  Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community. , 2001, Molecular genetics and metabolism.

[33]  J. Nuss,et al.  Current therapies and emerging targets for the treatment of diabetes. , 2001, Current pharmaceutical design.

[34]  F. R. van der Leij,et al.  Molecular enzymology of carnitine transfer and transport. , 2001, Biochimica et biophysica acta.

[35]  X. Ariza,et al.  A Concise Synthesis of (-)-Methylenolactocin and (-)-Phaseolinic Acid from (6S,9S)-Tetradec-7-yne-6,9-diol , 2001 .

[36]  N. Price,et al.  Identification of Positive and Negative Determinants of Malonyl-CoA Sensitivity and Carnitine Affinity within the Amino Termini of Rat Liver- and Muscle-type Carnitine Palmitoyltransferase I* , 2000, The Journal of Biological Chemistry.

[37]  D. Sharma,et al.  Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. , 2000, Molecular endocrinology.

[38]  E. Crockett,et al.  Endpoint fluorometric assays for determining activities of carnitine palmitoyltransferase and citrate synthase. , 2000, Analytical biochemistry.

[39]  C. Townsend,et al.  Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. , 2000, Science.

[40]  D. Ritchie,et al.  Protein docking using spherical polar Fourier correlations , 2000, Proteins.

[41]  H. Zhu,et al.  The first 28 N-terminal amino acid residues of human heart muscle carnitine palmitoyltransferase I are essential for malonyl CoA sensitivity and high-affinity binding. , 2000, Biochemistry.

[42]  H. Zhu,et al.  Functional characterization of mammalian mitochondrial carnitine palmitoyltransferases I and II expressed in the yeast Pichia pastoris. , 2000, The Journal of nutrition.

[43]  F. Hegardt,et al.  Identification of the two histidine residues responsible for the inhibition by malonyl‐CoA in peroxisomal carnitine octanoyltransferase from rat liver , 2000, FEBS letters.

[44]  C. Townsend,et al.  Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. , 2000, Cancer research.

[45]  V. Zammit The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. , 1999, The Biochemical journal.

[46]  D. Hardie,et al.  AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.

[47]  I R Vetter,et al.  Effector Recognition by the Small GTP-binding Proteins Ras and Ral* , 1999, The Journal of Biological Chemistry.

[48]  V A Zammit,et al.  Carnitine acyltransferases: functional significance of subcellular distribution and membrane topology. , 1999, Progress in lipid research.

[49]  H. Zhu,et al.  A Single Amino Acid Change (Substitution of Glutamate 3 with Alanine) in the N-terminal Region of Rat Liver Carnitine Palmitoyltransferase I Abolishes Malonyl-CoA Inhibition and High Affinity Binding* , 1999, The Journal of Biological Chemistry.

[50]  Demetrios Vavvas,et al.  Malonyl-CoA, fuel sensing, and insulin resistance. , 1999, American journal of physiology. Endocrinology and metabolism.

[51]  D. Carling,et al.  Evidence that the AMP‐activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components , 1998, FEBS letters.

[52]  J. McGarry,et al.  Roles of the N- and C-terminal domains of carnitine palmitoyltransferase I isoforms in malonyl-CoA sensitivity of the enzymes: insights from expression of chimaeric proteins and mutation of conserved histidine residues. , 1998, The Biochemical journal.

[53]  Joseph A. DiGiuseppe,et al.  Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. , 1998, Cancer research.

[54]  C N Cronin,et al.  Redesign of Choline Acetyltransferase Specificity by Protein Engineering* , 1998, The Journal of Biological Chemistry.

[55]  T. Gulick,et al.  Expression of novel isoforms of carnitine palmitoyltransferase I (CPT-1) generated by alternative splicing of the CPT-ibeta gene. , 1998, The Biochemical journal.

[56]  J. Cregg,et al.  Deletion of the conserved first 18 N-terminal amino acid residues in rat liver carnitine palmitoyltransferase I abolishes malonyl-CoA sensitivity and binding. , 1998, Biochemistry.

[57]  J. Girard,et al.  Topological and functional analysis of the rat liver carnitine palmitoyltransferase 1 expressed in Saccharomyces cerevisiae , 1998, FEBS letters.

[58]  R. Anderson Carnitine palmitoyltransferase: a viable target for the treatment of NIDDM? , 1970, Current pharmaceutical design.

[59]  T. Gulick,et al.  Rat carnitine palmitoyltransferase Ibeta mRNA splicing isoforms. , 1998, Biochimica et biophysica acta.

[60]  J. Cregg,et al.  Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I. , 1997, Archives of biochemistry and biophysics.

[61]  P. Watkins Fatty acid activation. , 1997, Progress in lipid research.

[62]  J. McGarry,et al.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.

[63]  J. Graham,et al.  Subcellular fractionation : a practical approach , 1997 .

[64]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[65]  G. Velasco,et al.  Involvement of Ca2+/calmodulin-dependent protein kinase II in the activation of carnitine palmitoyltransferase I by okadaic acid in rat hepatocytes. , 1997, The Biochemical journal.

[66]  P. Watkins,et al.  Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase. , 1996, Journal of lipid research.

[67]  C. Sander,et al.  Errors in protein structures , 1996, Nature.

[68]  J. McGarry,et al.  Expression of a cDNA Isolated from Rat Brown Adipose Tissue and Heart Identifies the Product as the Muscle Isoform of Carnitine Palmitoyltransferase I (M-CPT I) , 1996, The Journal of Biological Chemistry.

[69]  M C Peitsch,et al.  ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. , 1996, Biochemical Society transactions.

[70]  B. Rost PHD: predicting one-dimensional protein structure by profile-based neural networks. , 1996, Methods in enzymology.

[71]  D S Goodsell,et al.  Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.

[72]  R A Sayle,et al.  RASMOL: biomolecular graphics for all. , 1995, Trends in biochemical sciences.

[73]  J. Girard,et al.  Hormonal and nutritional control of liver fatty acid oxidation and ketogenesis during development. , 1995, Biochemical Society transactions.

[74]  V. Anderson,et al.  13C NMR and 1H-1H NOEs of Coenzyme-A: Conformation of the Pantoic Acid Moiety , 1995 .

[75]  N. Yamazaki,et al.  High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: isolation and characterization of its cDNA clone , 1995, FEBS letters.

[76]  C. Sander,et al.  A method to predict functional residues in proteins , 1995, Nature Structural Biology.

[77]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[78]  H. Lodish,et al.  Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1994, Cell.

[79]  J. McGarry,et al.  Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. , 1994, The Journal of biological chemistry.

[80]  J. Girard,et al.  Expression of liver carnitine palmitoyltransferase I and II genes during development in the rat. , 1994, The Biochemical journal.

[81]  K. Kashfi,et al.  Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation. , 1994, Biochimica et biophysica acta.

[82]  K. Kashfi,et al.  Yonetani-Theorell analysis of hepatic carnitine palmitoyltransferase-I inhibition indicates two distinct inhibitory binding sites. , 1994, The Journal of biological chemistry.

[83]  L. Witters,et al.  Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. , 1993, The Journal of biological chemistry.

[84]  M. Sippl Recognition of errors in three‐dimensional structures of proteins , 1993, Proteins.

[85]  J. McGarry,et al.  Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. , 1993, The Journal of biological chemistry.

[86]  R. Ramsay,et al.  Malonyl-CoA inhibition of peroxisomal carnitine octanoyltransferase. , 1992, The Biochemical journal.

[87]  B. Fibich,et al.  Restoration of malonyl-CoA sensitivity of soluble rat liver mitochondria carnitine palmitoyltransferase by reconstitution with a partially purified malonyl-CoA binding protein. , 1992, Archives of biochemistry and biophysics.

[88]  R. Ramsay,et al.  Effect of carboxylic acid xenobiotics and their metabolites on the activity of carnitine acyltransferases. , 1991, The Biochemical journal.

[89]  J. Girard,et al.  Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes. , 1990, The Biochemical journal.

[90]  C. Slaughter,et al.  Cloning, sequencing, and expression of a cDNA encoding rat liver mitochondrial carnitine palmitoyltransferase II. , 1990, The Journal of biological chemistry.

[91]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[92]  James J. P. Stewart,et al.  MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..

[93]  D. Taylor,et al.  A simple enzymatic method for the preparation of radiolabeled erucoyl-CoA and other long-chain fatty acyl-CoAs and their characterization by mass spectrometry. , 1990, Analytical biochemistry.

[94]  P. Selby,et al.  Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs. , 1989, Trends in pharmacological sciences.

[95]  J. Reardon Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition. , 1989, The Journal of biological chemistry.

[96]  K. Thampy Formation of malonyl coenzyme A in rat heart. Identification and purification of an isozyme of A carboxylase from rat heart. , 1989, The Journal of biological chemistry.

[97]  D. Stump,et al.  Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. , 1988, The Journal of clinical investigation.

[98]  S. Wakil,et al.  Regulation of acetyl-coenzyme A carboxylase. I. Purification and properties of two forms of acetyl-coenzyme A carboxylase from rat liver. , 1988, The Journal of biological chemistry.

[99]  D. Stump,et al.  Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[100]  P E Declercq,et al.  Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. , 1987, The Journal of biological chemistry.

[101]  J. McGarry,et al.  Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. , 1987, The Journal of biological chemistry.

[102]  A. Engel,et al.  Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle. , 1987, The Biochemical journal.

[103]  J. Morrison,et al.  Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues. , 1986, Biochimica et biophysica acta.

[104]  V. Zammit,et al.  Binding of [14C]malonyl-CoA to rat liver mitochondria after blocking of the active site of carnitine palmitoyltransferase I. Displacement of low-affinity binding by palmitoyl-CoA. , 1986, The Biochemical journal.

[105]  V. Zammit,et al.  Effects of incubation at physiological temperatures on the concentration-dependence of [2-14C]malonyl-CoA binding to rat liver mitochondria. , 1985, The Biochemical journal.

[106]  E. Saggerson,et al.  Interacting effects of L-carnitine and malonyl-CoA on rat liver carnitine palmitoyltransferase. , 1985, The Biochemical journal.

[107]  W. Stremmel,et al.  Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. , 1985, The Journal of clinical investigation.

[108]  E. Saggerson,et al.  Binding of malonyl-CoA to isolated mitochondria. Evidence for high- and low-affinity sites in liver and heart and relationship to inhibition of carnitine palmitoyltransferase activity. , 1984, The Biochemical journal.

[109]  V. Zammit,et al.  Changes in the ability of malonyl-CoA to inhibit carnitine palmitoyltransferase I activity and to bind to rat liver mitochondria during incubation in vitro. Differences in binding at 0 degree C and 37 degrees C with a fixed concentration of malonyl-CoA. , 1984, The Biochemical journal.

[110]  J. McGarry,et al.  Effects of pH on the interaction of substrates and malonyl-CoA with mitochondrial carnitine palmitoyltransferase I. , 1984, The Biochemical journal.

[111]  V. Zammit Time-dependence of inhibition of carnitine palmitoyltransferase I by malonyl-CoA in mitochondria isolated from livers of fed or starved rats. Evidence for transition of the enzyme between states of low and high affinity for malonyl-CoA. , 1984, The Biochemical journal.

[112]  C. Long,et al.  Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. , 1983, The Biochemical journal.

[113]  R. Harris,et al.  Effect of pH on malonyl-CoA inhibition of carnitine palmitoyltransferase I. , 1983, The Biochemical journal.

[114]  E. Saggerson Carnitine acyltransferase activities in rat liver and heart measured with palmitoyl-CoA and octanoyl-CoA. Latency, effects of K+, bivalent metal ions and malonyl-CoA. , 1982, The Biochemical journal.

[115]  E. Saggerson,et al.  Malonyl CoA inhibition of carnitine acyltransferase activities , 1982, FEBS letters.

[116]  E. Saggerson,et al.  Effects of fasting and malonyl CoA on the kinetics of carnitine palmitoyltransferase and carnitine octanoyltransferase in intact rat liver mitochondria , 1981, FEBS letters.

[117]  E. Saggerson,et al.  Carnitine palmitoyltransferase and carnitine octanoyltransferase activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart , 1981, FEBS letters.

[118]  J. Gollan,et al.  Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances. , 1981, Science.

[119]  G. Tutwiler,et al.  Inhibition of mitochondrial carnitine palmitoyl transferase by 2-tetradecylglycidic acid (McN-3802) (preliminary communication). , 1980, Life sciences.

[120]  P. Seglen Preparation of isolated rat liver cells. , 1976, Methods in cell biology.

[121]  I. H. Segel Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .

[122]  J. Bremer,et al.  The mechanism of substrate inhibition of palmityl coenzyme A:carnitine palmityltransferase by palmityl coenzyme A. , 1967, The Journal of biological chemistry.